Digital Behavioral Therapy Improves Outcome in Patients With Axial Spondyloarthritis and Persistent Pain: A Randomized Controlled Trial
The ACT app demonstrated a meaningful reduction in pain-related life interference, supporting that DHAs might become a complementary tool in managing pain for patients with axSpA. Studies about improving adherence to DHAs are warranted.
Authors
- Uta Kiltz (ORCID: https://orcid.org/0000-0001-5668-4497)
- Imke Redeker (ORCID: https://orcid.org/0000-0003-3377-2683)
- D. Krause (ORCID: https://orcid.org/0000-0002-0600-2803)
- B. Mintrop
- DAVID M. KIEFER (ORCID: https://orcid.org/0000-0003-1602-7649)
- Xenofon Baraliakos (ORCID: https://orcid.org/0000-0002-9475-9362)
- Y. Sonkaya
- M. Voglau
Institutions
- Rheumazentrum Ruhrgebiet (DE)
- Klinikum Oldenburg (DE)
- Rheumatology Consultants (US)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1002/acr.25679
- Citations
- 2
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Ruhr-Universität Bochum